Infectious Disease
Anti-tuberculosis drug resistance mutation (Isoniazid) [Sequencing]
AC-GCL-M338 · GC Labs
Anti-tuberculosis drug resistance mutation (Isoniazid) [Sequencing] is available through Advanced Consensus and performed by GC Labs. It is part of our infectious disease menu and is ordered the same way as any other test on it — tell us the clinical question and we will confirm the pathway and what to collect.
Order this test
Send the clinical question and specimen details and AC confirms the pathway, collection requirements, and logistics.
Order in the portalNot a client yet? Ask usHow ordering works →Test details
- Test code
- AC-GCL-M338
- Performing lab
- GC Labs
- Clinical area
- Infectious Disease
- Method
- Sanger sequencing
- Specimen
- Conical tube (sterilized container), Medium, Sterile container for Sputum
- Turnaround
- ~15 days
Turnaround is quoted end to end — the reference laboratory’s processing time plus courier transit from Jordan, 5 days to Korea and 8 days to the United States. It is indicative, not a guarantee, and may vary with specimen quality and shipment timing.
Sample requirements
Specimen: Strains Sputum Bronchial washing. Container: Conical tube (sterilized container), Medium, Sterile container for Sputum. Storage: Refrigerated. Stability: Refrigerated (3 days). Note: Anti-tuberculosis drug resistance [sequencing]; panel test
Other tests in Infectious Disease
- Adenovirus AntigenAC-GCL-B108
- Anti-tuberculosis drug resistance mutation (Rifampicin) [Sequencing]AC-GCL-M337
- Antifungal susceptibility testingAC-GCL-B337
- Antimicrobial susceptibility testingAC-GCL-B405
- Antimicrobial susceptibility testing (multidrug resistance)AC-GCL-Q565
- Antistrep-O (ASO, Quantitative)AC-GCL-S831
For healthcare professionals. Tests are ordered and interpreted in consultation with a qualified physician. Test names are the performing laboratory’s own. Pricing is per-institution and confirmed on request.